Clinical Trials
13
Active:2
Completed:4
Trial Phases
3 Phases
Phase 1:3
Phase 2:1
Phase 3:9
Drug Approvals
6
SFDA:6
Drug Approvals
HADLIMA 40MG/0.8ML INJECTION IN PRE-FILLED SYRING
- Approval Date
- Jul 18, 2025
- Company
- Catalent Belgium SA
SFDA
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 3
9 (69.2%)Phase 1
3 (23.1%)Phase 2
1 (7.7%)No trials found
News
No news found